blue cross blue shield reverse course on glp 1 of Mass. sees gains after years of GLP-1-related losses California's cuts to weight loss

[DOI] [PMC free article] [PubMed] [Google Scholar] 320.Pavithra PS, Mehta A, Verma RS

The GLP-1, amylin and glucagon hormones also get off track, making it harder to manage hunger and blood sugar

These products are not FDA-approved, have not been reviewed by FDA for safety and effectiveness, and FDA cautions they can lead to serious and potentially life-threatening adverse health consequences including infections and sepsis. Knock-off versions of semaglutide pose significant threats to peoples health and safety, a Novo Nordisk spokesperson said in an email to Healio | Endocrine Today

Healthcare professionals must understand and consistently apply aseptic principles when using multi-dose vials